ABOUT US
Jénine Smith Inc. represents a distinguished range of clinical psychologists dedicated to pioneering innovative approaches to mental health treatment. Since 2018, Jenine Smith Inc has taken a keen interest in the ground-breaking work of Dr G. Frank Lawlis and Dr George Lindenfeld, two eminent figures in the field of medical and neuro psychology. Specifically, her keen interest in how the brains plasticity is nurtured and optimised through a special form of biofeedback is what prompted her to link up with Dr George Lindenfeld.
Dr G. Frank Lawlis is renowned worldwide for his expertise in treating attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD). His pioneering work extends to areas such as pain management, addiction treatment, and emotional regulation. Dr Lawlis developed the Bio Acoustical Utilization Device, initially intended for ADD/ADHD treatment, which was later found to be highly effective in addressing a range of emotional issues. The device is FDA*-approved (21 CFR 882.5050)as a class 2 accessory medical device and this innovation has garnered recognition for its role in enhancing brain plasticity through specific targeted biofeedback.
Dr George Lindenfeld, a clinical psychologist with extensive experience in treating PTSD, has significantly contributed to the field through his certification in EEG Biofeedback and ground-breaking research. His endorsement of the Bio Acoustical Utilization Device as a transformative therapeutic tool underscores its efficacy in PTSD treatment, with patients experiencing remarkable symptom reduction within just a few sessions. Dr Lindenfeld's studies, including publications in esteemed journals such as Military Psychology, attests to the credibility and effectiveness of this modality.
Jénine Smith received specialised training and certification from Dr Lindenfeld's RESET Therapy Professional Institute, positioning her as a leader in the application of Bio Acoustical Utilization Device within her clinical practices. Alongside her team, Jénine has harnessed the power of BBRT to address a wide range of clinical presentations, including PTSD/Complex PTSD, Depression, Anxiety, Addiction, Self Harm, ADHD,chronic pain and a host of other debilitating symptoms. The results have been nothing short of revolutionary.
BBRT is a groundbreaking therapeutic process that can be used in conjunction with other treatment modalities. It incorporates neuro-modulation to stimulate the brain to generate Binaural Beats inducing beneficial effects on various conditions. This treatment is a non-invasive intervention which utilizes brief exposure therapy combined with acoustical neurostimulation. The beneficial effects on symptom relief is groundbreaking.This rapidly modifies varied memory circuits in the brain in order to relieve the targeted symptoms. The treatment process intercepts the selected and targeted memory and related cognitive processes. This emotionally charged memory is restored repeatedly after it is selectively lit up in the emotional part of the brain (amygdala) through intentional focus. Even though the treatment modality can be used as a stand alone intervention, it has great appeal in that it can be incorporated into existing clinical practice as a complimentary non-invasive treatment option, if you feel it is needed.
The approach is supported by numerous case studies and Dr Lindenfeld’s extensive publications, demonstrating its efficacy in rapidly modifying memory circuits to alleviate targeted symptoms
*Food and drug Administration (FDA) is responsible for protecting public health by assuring the efficacy, safety, and security of human and veterinary pharmaceuticals, biological products, medical devices, food supply, cosmetics and products that emit radiation. As an administration the FDA also provides evidenced based health information to the public, for their best interests. In the case of the Bio Acoustical Utilization device, the fact that it has FDA approval means that the device’s safety and effectiveness has been reviewed by the FDA and that the device’s known and potential benefits outweigh the known and potential risks.
The use of an FDA-approved Bio Acoustical Utilization Device in BBRT ensures safety with no or brief side effects, such as slight dizziness directly after the treatment. The use of the Bio Acoustical Utilization device has been experienced as safe even with extended use in clinical applications. This makes BBRT a compelling treatment option with no risk, promising transformative changes in psychotherapy. Jénine Smith is committed to advancing these principles, believing they will revolutionize mental health treatment paradigms.
Request for Access to Records Form | Outcome of Request and of Fees Payable Form
© 2024 Jénine Smith Inc.. Website designed & hosted by Personalised Promotions in association with SA Medical Specialists.